NovAccess Global (OTCMKTS:XSNX) Announces Earnings Results

NovAccess Global (OTCMKTS:XSNX) announced its earnings results on Wednesday. The company reported ($0.06) EPS for the quarter, Zacks reports.

NovAccess Global Trading Down 100.0%

NovAccess Global has a 1-year low of $0.00 and a 1-year high of $0.05.

NovAccess Global Company Profile

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.